Laura Lee Sandler, Chief Operating Officer at Oruka Therapeutics, Inc. (ORKA), sold 5,000 shares at $33.28 ($168K) on 2026-03-02, disclosed to the SEC on 2026-03-02.
Scheduled sale ($168k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.28 | 2,325 | $77K | 46.1% |
| 2 | $33.81 | 2,675 | $90K | 53.9% |
| Total | $33.56 avg | 5,000 | $168K | 100% |
| Filing → |
| ORKA | SELL | 2026-06-15 | $42K | — | Filing → |
| ORKA | SELL | 2026-05-01 | $319K | — | Filing → |
| ORKA | SELL | 2026-03-17 | $25K | — | Filing → |